Journey Medical Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio1.461.350.461.42
P/B Ratio4.075.242.012.13
Price/Tangible Book1692.203.04
Price/FCF20.34
Price/OCF20.34
Enterprise Value Ratios
EV/Revenue1.431.070.331.73
EV/EBITDA17.57
EV/EBIT79.43
EV/FCF16.22
Profitability & Returns
Return on Equity (ROE)-0.73%-0.21%-1.00%-1.68%0.81%
Return on Assets (ROA)-0.11%0.01%-0.17%-0.16%0.11%
Return on Invested Capital (ROIC)-0.76%0.10%-4.04%-1.70%0.41%
Return on Capital Employed (ROCE)-0.30%0.03%-0.72%-0.41%0.33%
Leverage & Solvency Ratios
Debt/Equity1.280.871.570.211.75
Debt/EBITDA3.591.93
Debt/FCF3.383.52
Liquidity Ratios
Current Ratio1.371.351.161.641.26
Quick Ratio0.871.020.901.401.15
Efficiency Ratios
Asset Turnover0.710.870.730.851.04
Inventory Turnover1.701.882.564.5412.91
Yield & Distribution Ratios
Earnings Yield-0.18%-0.04%-0.87%-0.49%
FCF Yield-0.11%0.05%-0.40%-0.02%
Buyback Yield-0.12%-0.04%-0.72%0.06%-0.08%